3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
55
Recurrence
7
Lymphoma
6
Neoplasms, Plasma Cell
5
Immunoglobulin Light-chain Amyloidosis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Paraproteinemias
2
Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
beta-Thalassemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Plasmablastic Lymphoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphadenopathy
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Magnetic Resonance Imaging
2
Cryosurgery
2
imetelstat
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
S-Adenosylmethionine
1
Prostatectomy
1
Pluvicto
1
Observation
1
Nivolumab
1
Mammography
1
High-Intensity Interval Training
1
Hematologic Tests
1
Fluorodeoxyglucose F18
1
Exercise
1
Equipment and Supplies
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnosis, Computer-Assisted
1
Bupivacaine
1
Blood Specimen Collection
1
Artificial Intelligence
1
Arginine
1
Acupressure
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease
×
Bortezomib
×
90 days
×
Clear all
No trials found.